Clinical Trials Browser

Interventional × Risedronic Acid × Thoracic × Clear all

NCT03861091 2023-07-27

Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

Phase 2 Completed

84 enrolled 13 charts

Lung Neoplasms